Home > Insider Trading > Filing (0001209191-19-058413)

Filing Details

Accession Number:: 0001209191-19-058413
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-29 14:40:51
Reporting Period:: 2019-11-26

Accepted Time:: 2019-11-29 14:40:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1649904	Rhythm Pharmaceuticals Inc.	RYTM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1473930	Todd Foley	C/O Mpm Asset Management 450 Kendall Street Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-11-26	74,225	$23.31	2,570,355	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2019-11-27	34,960	$22.91	2,535,395	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2019-11-29	18,359	$22.67	2,517,036	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Shares were sold as follows: 71,449 by BV V and 2,776 by AM BV5.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $22.71 to $23.56. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Shares are held as follows: 2,474,236 by BV V and 96,119 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Shares were sold as follows: 33,653 by BV V and 1,307 by AM BV5.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $22.41 to $23.385. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Shares are held as follows: 2,440,583 by BV V and 94,812 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Shares were sold as follows: 17,672 by BV V and 687 by AM BV5.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $22.36 to $22.95. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Shares are held as follows: 2,422,911 by BV V and 94,125 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.